Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 5.9B | 8.6B | 8.7B | 7.5B |
Cost of revenue | 3.6B | 4.8B | 4.7B | 4.2B |
Gross profit | 2.3B | 3.8B | 4.1B | 3.3B |
Operating expense | ||||
Research & development | 337M | 425M | 348M | 240M |
Selling general and admin | 162M | 337M | 339M | 298M |
Other operating expenses | 542M | 504M | 506M | 413M |
Operating income | 439M | 1.7B | 2.1B | 1.8B |
Non operating interest income | ||||
Income | 77M | 63M | 77M | 29M |
Expense | 1M | 0 | — | — |
Other income expense | — | — | — | — |
Pretax income | 674M | 2.1B | 2.5B | 2.1B |
Tax provision | 247M | 625M | 201M | 343M |
Net income | 427M | 1.5B | 2.3B | 1.7B |
Basic EPS | 77.3 | 271.9 | 399.9 | 305.0 |
Diluted EPS | 77.3 | 271.9 | 399.9 | 305.0 |
Basic average shares | 5.5M | 5.6M | 5.6M | 5.6M |
Diluted average shares | 5.5M | 5.6M | 5.6M | 5.6M |
EBITDA | 678M | 2.2B | 2.2B | 1.8B |
Net income from continuing op. | 674M | 2.1B | 2.5B | 2.1B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |